Patents by Inventor Philippe DANHIER

Philippe DANHIER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220218633
    Abstract: This invention pertains to a compound and a composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder.
    Type: Application
    Filed: May 12, 2020
    Publication date: July 14, 2022
    Inventors: Philippe DANHIER, Pascale AZZAM
  • Publication number: 20220008455
    Abstract: The present invention concerns a compound and composition for use in the preventive and/or curative treatment of diseases of the central nervous system characterised by a decline in neuronal plasticity, in particular a decline in synaptic plasticity, for example in the treatment of diseases of the central nervous system affecting cognitive processes such as learning, perception, attention, reasoning, language and/or memory, in the treatment of diseases of the central nervous system such as neurodegenerative diseases including Parkinson's disease, Alzheimer's disease and/or amyotrophic lateral sclerosis, in the treatment of diseases of the central nervous system responsible for mood disorders, hyperexcitability, hyperactivity and/or stress, and in the treatment of neurological conditions such as epilepsy, said compound being magnesium N-acetyl taurinate.
    Type: Application
    Filed: September 22, 2021
    Publication date: January 13, 2022
    Inventors: Philippe DANHIER, Pascale AZZAM
  • Patent number: 11053194
    Abstract: The present invention concerns a process for the production of magnesium N-acetyl taurinate, in particular a process for the production of magnesium N-acetyltaurinate dihydrate.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: July 6, 2021
    Assignee: SYNAPHARM INDUSTRIAL SYNTHESIS
    Inventors: Philippe Danhier, Pascale Azzam
  • Publication number: 20200392078
    Abstract: The present invention concerns a process for the production of magnesium N-acetyl taurinate, in particular a process for the production of magnesium N-acetyltaurinate dihydrate.
    Type: Application
    Filed: June 9, 2020
    Publication date: December 17, 2020
    Inventors: Philippe Danhier, Pascale Azzam
  • Publication number: 20200237812
    Abstract: The present invention concerns a compound and composition for use in the preventive and/or curative treatment of diseases of the central nervous system characterised by a decline in neuronal plasticity, in particular a decline in synaptic plasticity, for example in the treatment of diseases of the central nervous system affecting cognitive processes such as learning, perception, attention, reasoning, language and/or memory, in the treatment of diseases of the central nervous system such as neurodegenerative diseases including Parkinson's disease, Alzheimer's disease and/or amyotrophic lateral sclerosis, in the treatment of diseases of the central nervous system responsible for mood disorders, hyperexcitability, hyperactivity and/or stress, and in the treatment of neurological conditions such as epilepsy, said compound being magnesium N-acetyl taurinate
    Type: Application
    Filed: September 26, 2018
    Publication date: July 30, 2020
    Inventors: Philippe DANHIER, Pascale AZZAM